110 related articles for article (PubMed ID: 8195025)
1. Does DNA targeting affect the cytotoxicity and cell uptake of basic nitroquinoline bioreductive drugs?
Siim BG; Denny WA; Wilson WR
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):311-5. PubMed ID: 8195025
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and radiolytic reduction of 4-alkylamino-5-nitroquinoline bioreductive drugs. Relationship to hypoxia-selective cytotoxicity.
Siim BG; Atwell GJ; Wilson WR
Biochem Pharmacol; 1994 Oct; 48(8):1593-604. PubMed ID: 7980625
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugs.
Siim BG; Atwell GJ; Anderson RF; Wardman P; Pullen SM; Wilson WR; Denny WA
J Med Chem; 1997 Apr; 40(9):1381-90. PubMed ID: 9135035
[TBL] [Abstract][Full Text] [Related]
4. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
[TBL] [Abstract][Full Text] [Related]
5. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
Siim BG; Atwell GJ; Wilson WR
Br J Cancer; 1994 Oct; 70(4):596-603. PubMed ID: 7917903
[TBL] [Abstract][Full Text] [Related]
6. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.
Siim BG; Hicks KO; Pullen SM; van Zijl PL; Denny WA; Wilson WR
Biochem Pharmacol; 2000 Oct; 60(7):969-78. PubMed ID: 10974206
[TBL] [Abstract][Full Text] [Related]
7. Efficient redox cycling of nitroquinoline bioreductive drugs due to aerobic nitroreduction in Chinese hamster cells.
Siim BG; Wilson WR
Biochem Pharmacol; 1995 Jun; 50(1):75-82. PubMed ID: 7605348
[TBL] [Abstract][Full Text] [Related]
8. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
9. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
Wilson WR; Van Zijl P; Denny WA
Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839
[TBL] [Abstract][Full Text] [Related]
10. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
Moselen JW; Hay MP; Denny WA; Wilson WR
Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
[TBL] [Abstract][Full Text] [Related]
11. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
[TBL] [Abstract][Full Text] [Related]
13. Aliphatic amine N-oxides of DNA binding agents as bioreductive drugs.
Patterson LH; Craven MR; Fisher GR; Teesdale-Spittle P
Oncol Res; 1994; 6(10-11):533-8. PubMed ID: 7620222
[TBL] [Abstract][Full Text] [Related]
14. Role of the nitro functionality in the DNA binding of 3-nitro-10-methylbenzothiazolo[3,2-a]quinolinium chloride.
Colón IG; González FA; Cordero M; Zayas B; Velez C; Cox O; Kumar A; Alegría AE
Chem Res Toxicol; 2008 Sep; 21(9):1706-15. PubMed ID: 18759504
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
Skov KA; Adomat H; Doedee M; Farrell N
Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
[TBL] [Abstract][Full Text] [Related]
16. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxia-selective cytotoxin tirapazamine.
Hay MP; Pruijn FB; Gamage SA; Liyanage HD; Kovacs MS; Patterson AV; Wilson WR; Brown JM; Denny WA
J Med Chem; 2004 Jan; 47(2):475-88. PubMed ID: 14711317
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
[TBL] [Abstract][Full Text] [Related]
18. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
19. The effect of low pH and hypoxia on the cytotoxic effects of SR4233 and mitomycin C in vitro.
Skarsgard LD; Vinczan A; Skwarchuk MW; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):363-7. PubMed ID: 8195034
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and DNA lesions produced by mitomycin C and porfiromycin in hypoxic and aerobic EMT6 and Chinese hamster ovary cells.
Fracasso PM; Sartorelli AC
Cancer Res; 1986 Aug; 46(8):3939-44. PubMed ID: 3089583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
